Ali Kevin, CEO of Organon & Co. ($OGN), bought shares on the open market once in the last year, totaling nearly $300,000, with his most recent purchase on May 5, 2025. His buying activity ranks 1,162nd among roughly 5,000 insiders, below the average purchase of $1.5 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | P | Common Stock | 34000 | $8.81 | 282,731.1570 | 259,152,000 | 13.67% | 0.01% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 48758 | $0.00 | 248,677.1570 | 259,152,000 | 24.39% | 0.02% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 26964 | $14.51 | 221,713.1570 | 259,152,000 | 10.84% | 0.01% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 38974 | $0.00 | 260,687.1570 | 259,152,000 | 17.58% | 0.02% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 21553 | $14.51 | 239,134.1570 | 259,152,000 | 8.27% | 0.01% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 21472 | $0.00 | 260,606.1570 | 259,152,000 | 8.98% | 0.01% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 11875 | $14.51 | 248,731.1570 | 259,152,000 | 4.56% | 0.00% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Stock Option (right to buy) | 1072607 | $0.00 | 1,072,607.0000 | 259,152,000 | 9999.99% | 0.41% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Restricted Stock Units | 218267 | $0.00 | 218,267.0000 | 259,152,000 | 9999.99% | 0.08% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 48758 | $0.00 | 97,518.0000 | 259,152,000 | 33.33% | 0.02% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 38974 | $0.00 | 38,974.0000 | 259,152,000 | 50.00% | 0.02% |
| March 31, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 21472 | $0.00 | 0.0000 | 259,152,000 | 100.00% | 0.01% |
| Feb. 20, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Common Stock | 84222 | $0.00 | 229,110.0000 | 259,152,000 | 58.13% | 0.03% |
| Feb. 20, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 46575 | $14.92 | 182,535.0000 | 259,152,000 | 20.33% | 0.02% |
| Feb. 20, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Common Stock | 15423 | $0.00 | 197,958.0000 | 259,152,000 | 8.45% | 0.01% |
| Feb. 20, 2025 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 8529 | $15.29 | 199,919.1570 | 259,152,000 | 4.09% | 0.00% |
| Sept. 3, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Common Stock | 21567 | $0.00 | 156,815.0000 | 256,270,000 | 15.95% | 0.01% |
| Sept. 3, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 11927 | $20.35 | 144,888.0000 | 256,270,000 | 7.61% | 0.00% |
| May 4, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 22161 | $0.00 | 147,504.0000 | 256,270,000 | 17.68% | 0.01% |
| May 4, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 12256 | $19.61 | 135,248.0000 | 256,270,000 | 8.31% | 0.00% |
| May 4, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 22161 | $0.00 | 0.0000 | 256,270,000 | 100.00% | 0.01% |
| March 31, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 21471 | $0.00 | 119,797.0000 | 256,270,000 | 21.84% | 0.01% |
| March 31, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 11874 | $18.80 | 107,923.0000 | 256,270,000 | 9.91% | 0.00% |
| March 31, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 38973 | $0.00 | 146,896.0000 | 256,270,000 | 36.11% | 0.02% |
| March 31, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 21553 | $18.80 | 125,343.0000 | 256,270,000 | 14.67% | 0.01% |
| March 31, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 21471 | $0.00 | 21,472.0000 | 256,270,000 | 50.00% | 0.01% |
| March 31, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 38973 | $0.00 | 77,948.0000 | 256,270,000 | 33.33% | 0.02% |
| March 29, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Restricted Stock Units | 146276 | $0.00 | 146,276.0000 | 256,270,000 | 9999.99% | 0.06% |
| March 29, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Stock Option (right to buy) | 599128 | $0.00 | 599,128.0000 | 256,270,000 | 9999.99% | 0.23% |
| Feb. 28, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 88121 | $0.00 | 138,740.0000 | 256,270,000 | 174.09% | 0.03% |
| Feb. 28, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 40414 | $18.04 | 98,326.0000 | 256,270,000 | 29.13% | 0.02% |
| Feb. 28, 2024 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 88121 | $0.00 | 0.0000 | 256,270,000 | 100.00% | 0.03% |
| May 4, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 22158 | $0.00 | 62,873.0000 | 255,169,000 | 54.42% | 0.01% |
| May 4, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 12254 | $24.24 | 50,619.0000 | 255,169,000 | 19.49% | 0.00% |
| May 4, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 22158 | $0.00 | 22,161.0000 | 255,169,000 | 50.00% | 0.01% |
| May 1, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 2711 | $0.00 | 42,206.0000 | 255,169,000 | 6.86% | 0.00% |
| May 1, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 1491 | $24.63 | 40,715.0000 | 255,169,000 | 3.53% | 0.00% |
| May 1, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 2711 | $0.00 | 0.0000 | 255,169,000 | 100.00% | 0.00% |
| March 31, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 21471 | $0.00 | 51,390.0000 | 255,169,000 | 71.76% | 0.01% |
| March 31, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 11895 | $23.09 | 39,495.0000 | 255,169,000 | 23.15% | 0.00% |
| March 31, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 21471 | $0.00 | 42,943.0000 | 255,169,000 | 33.33% | 0.01% |
| March 31, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Restricted Stock Units | 116921 | $0.00 | 116,921.0000 | 255,169,000 | 9999.99% | 0.05% |
| March 31, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | A | Stock Option (right to buy) | 419847 | $0.00 | 419,847.0000 | 255,169,000 | 9999.99% | 0.16% |
| Feb. 28, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Common Stock | 11393 | $0.00 | 36,306.0000 | 255,169,000 | 45.73% | 0.00% |
| Feb. 28, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | F | Common Stock | 6387 | $25.09 | 29,919.0000 | 255,169,000 | 17.59% | 0.00% |
| Feb. 28, 2023 | Organon & Co. | $OGN | Ali Kevin | Chief Executive Officer | M | Restricted Stock Units | 11393 | $0.00 | 0.0000 | 255,169,000 | 100.00% | 0.00% |